Vident Investment Advisory’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-61,062
| Closed | -$2.24M | – | 953 |
|
|
2018
Q3 | $2.24M | Sell |
61,062
-4,070
| -6% | -$150K | 0.09% | 299 |
|
|
2018
Q2 | $2.28M | Buy |
65,132
+22,803
| +54% | +$798K | 0.09% | 303 |
|
|
2018
Q1 | $1.7M | Buy |
42,329
+11,501
| +37% | +$461K | 0.07% | 332 |
|
|
2017
Q4 | $1.16M | Buy |
30,828
+8,865
| +40% | +$332K | 0.05% | 362 |
|
|
2017
Q3 | $1.17M | Buy |
21,963
+552
| +3% | +$29.4K | 0.06% | 346 |
|
|
2017
Q2 | $1.22M | Buy |
21,411
+5,602
| +35% | +$319K | 0.1% | 300 |
|
|
2017
Q1 | $850K | Buy |
15,809
+2,634
| +20% | +$142K | 0.08% | 319 |
|
|
2016
Q4 | $751K | Buy |
13,175
+1,577
| +14% | +$89.9K | 0.09% | 304 |
|
|
2016
Q3 | $721K | Sell |
11,598
-462
| -4% | -$28.7K | 0.1% | 311 |
|
|
2016
Q2 | $682K | Buy |
12,060
+2,668
| +28% | +$151K | 0.1% | 327 |
|
|
2016
Q1 | $602 | Buy |
9,392
+4,383
| +88% | +$281 | 0.04% | 366 |
|
|
2015
Q4 | $705K | Buy |
+5,009
| New | +$705K | 0.09% | 347 |
|